Existing law, until January 1, 2028, and to the extent funds are made available for these purposes, requires the State Department of Public Health to collect data on the incidence of neurodegenerative disease in California. Existing law requires a hospital, facility, physician and surgeon, or other health care provider diagnosing or providing treatment to a patient for a neurodegenerative disease to report each case of a neurodegenerative disease to the department, as prescribed. Existing law requires the department to designate the specified neurodegenerative diseases required to be reported in the state or any part of the state. Existing law specifies that for this purpose, “neurodegenerative disease” may include, but need not be limited to, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, multiple sclerosis, and Huntington’s disease.

This bill would specify that “neurodegenerative disease” includes frontotemporal degeneration (FTD) and other dementias. The bill would extend the requirements of these provisions until January 1, 2030.